﻿IX. B, 1 



Willets: Treatment of Entamoebiasis 



115 



Table V. — Cases treated with neosalvarsan. 



(Dose 0.9 gram.) 



No. of 

 case. 



Laboratory exami- 

 nations. 



Treat- 

 ment 



1 

 Number 

 of con- 

 secutive 



No. of 

 case. 



Laboratory exami- 

 nations. 



Treat- 

 ment. 



Number 

 of con- 

 secutive 

 negative 



laboratory 

 exami- 

 nations 



before dis- 

 charge. 



Date. 



Result. 



Date. 



negative 

 laboratory 

 exami- 

 nations 

 before dis- 

 charge. 



Date. 



Result. 



Date. 





1913. 











1913. 







... 



1 



Jan. 4 

 Jan. 9 



-1- 



Jan. 5 -- 



1 ' 





Aug. 26 



-t- • 







- 



Jan. 9 — 



5.... 



Sept. 5 



- 



Sept. 2.. 



3 



2 



May 8 

 May 6 



+ 



[May 3 .. 



1 



Sept. 10 

 Sept. 24 







Sept. 11. 





/Aug. 3 



+ + 









Sept. 1 



+ 









Aug. 4 



+ + 









Sept. 13 



— 









Aug. 22 

 Aug. 27 





Aug. 9.. 



] 



6.-. 



Sept. 15 

 Sept. 16 





Sept. 7.. 



6 



3 



(Sept. 1 



- 



^Aug. 24. 



7 





Sept. 17 



— 









Sept. 5 



— 



Sept. 11. 







Sept. 23 



— 









Sept. 10 



— 









Sept. 3 



+ 









Sept. 17 

 Sept. 23 











7.... 



Sept. 18 

 Sept. 24 





Sept. 8.. 



3 





Aug. 23 



+ 









Isept. 26 



— 







4 



Sept. 6 



+ 



Sept. 1 - 



1 ^ 





Sept. 3 



+ 







Sept. 10 



— 



Sept. 8 . 





Sept. 6 



-1- 



Sept. 7-. 

 Sept. 10. 



2 





Sept. 12 



— 







8.... 



Sept. 16 

 Sept. 23 



4- 















Sept. 29 









Table VI. — Comparison of results of treatment in dysenteric cases. 



Cases. 



Treated with 

 ipecac. 



Treated with 

 emetine. 



Number. 



Per cent. 



Number. 



Per cent. 



Died 







1.000 

 10.000 



9.1 

 91.9 



Recovered symptomatically . ... 



10.00 

 4.00 

 2.00 



15.00 

 1.00 



62.5 

 25.0 

 12.5 



93.8 



6.2 



61.4 



Improved symptomatically 



Unimproved svmptomatically 



1 



Discharged: 



Negative microscopically 



7.000 

 4.000 



63.6 

 36.4 

 65.0 



Positive microscopically 



With two consecutive negatives* -. 



Average days for symptomatic recovery after treat- 

 ment began. 

 Average days to first of two final negatives 



8.10 



8.50 

 16.30 



16.67 



3.600 



8.250 

 0.287 



0.484 







Average grams of drug required for symptomatic re- 

 covery. 

 Average grams of drug to first of two final negatives ... 













' By actual examination and by estimation, see Table VIII. 



